Diabetes mellitus, type 2
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: Age above 18 years; be a carrier of DM2 with a diagnosis of at least five years; have availability of time for submission to the intervention sessions and who agree to participate in the study by means of the Free and Informed Consent Form.
Exclusion criteria
Exclusion criteria: Possess infection; inflammation or injury to the ear patch; make use of piercing, except normal earring; total or partial amputation or presence of lower limb injury; thrombosis in the lower limbs; neurological sequelae.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Expected outcome 1: Reduction of fasting glycemic levels to 100 mg / dl by means of a glycosimeter. Data from one week two before the intervention. | — |
Secondary
| Measure | Time frame |
|---|---|
| Expected outcome 2: Improvement of functional capacity and symptoms of lameness Intermittent assessed by means of the Six-minute Walk Test with at least one walk above 200m; one day after the end of the intervention and after a follow-up of 15 days.;Expected outcome 3: Improvement of pulmonary conditions to values between 103 mmHg for men and 70 mmHg to 77 mmHg for women in MIP. and values between 197mmHg to 218mmHg for men and 135mmHg to 145mmHg for women in the MEP .; evaluated by means of the manovacuometry one day after the end of the intervention and after a follow-up of 15 days.;Expected outcome 4: Reduction of the ischemic process in the lower limbs by means of the Index-Ankle-Brachial test for normal scores between 1.0 and 1.4, one day after the end of the intervention and after a 15-day follow-up.;Expected outcome 5: Central Nervous System Excitability by electroencephalogram, one day after the end of the intervention and after a 15-day follow-up.;Expected outcome 6: Evaluation of anthropometric data by electrical bioimpedance for values of normal variants according to sex, age, weight and body fat composition, one day after the end of the intervention and after a 15-day follow-up.;Expected outcome 7: To present a normal postural balance and plantar pressure <110N / cm² by means of the Baropodometer one day after the end of the intervention and after a 15-day follow-up.;Expected outcome 8: Improvement of quality of life through the Diabetes Quality of Life Measurement Questionnaire, one day after the end of the intervention and after a 15-day follow-up.;Expected outcome 9: Reduction of the classification of Moderate or High Risk for Low Risk of Diabetic Foot by an application, one day after the end of the intervention and after a follow-up of 15 days.;Expected outcome 10: Obtain a normal superficial plantar temperature between 35.5 and 37.0 ° C by means of the Thermographic Camera, one day after the end of the intervention and after a 15-day follow-up.;Expe | — |
Countries
Brazil
Contacts
Universidade Federal de Alfenas - UNIFAL